For the Quarter Ending June 2025
North America
• In June 2025, the Monocalcium Phosphate Spot Price rose sharply by 7.09%, reaching USD 1510/MT (CFR New York). This increase in prices was driven by a strong rebound in demand from downstream feed and supplement sectors as buyers rushed to replenish thinning inventories.
• May 2025 recorded a steep 10.48% price decline that reflected a sluggish offtake from the pharmaceutical and medical sectors. It was coupled with ample inventory coverage which led to soft market sentiment and reluctant buying activity.
• In April 2025, the Monocalcium Phosphate Price Index declined by 2.48% as high stock levels and subdued feed sector activity led buyers to defer procurement that contributed to a weak demand base.
• The Monocalcium Phosphate Demand Outlook improved in June, particularly from the animal nutrition and dietary supplement segments, as seasonal feed cycles began to influence bulk buying behaviour.
• Suppliers operated with uninterrupted production throughout Q2, and consistent feedstock availability ensured that the Monocalcium Phosphate Production Cost Trend remained stable to declining, particularly in May due to falling raw material input prices.
• US importers experienced smooth logistics and efficient port handling throughout the quarter, allowing for reliable delivery schedules that amplified the influence of demand on pricing.
• Inventory overhangs in May led to price suppression despite ample product availability, while June's restocking urgency reversed that sentiment rapidly, lifting the Monocalcium Phosphate Spot Price.
• Export pricing dynamics from Asia—particularly China—played a key role in shaping the US market trend, with lower FOB values in April–May translating to cheaper landed costs early in the quarter.
• Why did the price change in July 2025? With inventories largely replenished in June, and no major policy disruptions anticipated, the Monocalcium Phosphate Price Forecast for July 2025 suggests stable to moderately softening prices in the US, contingent on downstream consumption aligning with expectations.
APAC
• Monocalcium Phosphate Spot Price (FOB Shanghai) increased by 1.60% in June 2025, closing at USD 1270/MT, owing to a rebound in downstream procurement and thin inventories among domestic and international buyers.
• May 2025 saw a steep 12.89% price decline, attributed to oversupply, reduced phosphoric acid prices, and weakened pharma/medical sector demand, which all contributed to a bearish Monocalcium Phosphate Price Index.
• In April 2025, prices rose slightly by 0.70%, tempered by global trade frictions, especially the 145% U.S. tariff, which limited international purchasing volumes and constrained overall price movement.
• The Monocalcium Phosphate Demand Outlook strengthened in June, with feed additives, food fortification, and animal nutrition sectors boosting procurement after a prior month of caution.
• Monocalcium Phosphate Production Cost Trend in China dipped during May due to low phosphoric acid costs and high operational continuity across facilities, allowing manufacturers to offer lower prices temporarily.
• China's domestic and export supply chain performance remained smooth and efficient throughout Q2, facilitating quick response to demand shifts without bottlenecks or cost shocks.
• Exporters responded to June’s rebound by lifting offers, driven by renewed international interest and strategic restocking across Asia and the Middle East.
• Despite subdued pharma demand in May, animal feed and food supplement segments led the recovery, particularly in response to seasonal requirements in APAC consumer markets.
• Why did the price change in July 2025? With upstream costs starting to stabilize and inventories now more balanced, the Monocalcium Phosphate Price Forecast for APAC July 2025 suggests steady to mildly firm pricing, supported by ongoing restocking in Southeast Asia and South Asia.
Europe
• The Monocalcium Phosphate Spot Price (CFR Hamburg) rose by 3.76% in June 2025, reaching USD 1380/MT, propelled by inventory exhaustion and renewed buying interest from feed and supplement manufacturers.
• A sharp 12.79% price drop in May 2025 was driven by weak procurement from the pharma sector, as buyers held excess inventory and preferred drawing down existing stocks rather than purchasing anew.
• April 2025 saw a marginal 0.65% price dip, reflecting strategic procurement caution amidst smooth supply availability and subdued agricultural demand.
• The Monocalcium Phosphate Demand Outlook improved notably in June, especially from animal feed processors responding to seasonal production cycles and anticipating further price increases.
• Supply-side stability characterized the quarter, with no major logistics issues or policy constraints affecting European imports—this kept the Monocalcium Phosphate Production Cost Trend relatively flat.
• European buyers, especially in Germany, shifted from passive to active procurement in June, primarily due to lean inventory levels following a two-month lull.
• Global FOB pricing from Asia started strengthening in June, and this fed into Europe’s Monocalcium Phosphate Spot Price trajectory, reinforcing the bullish shift.
• The price recovery in June was not driven by speculative activity but rather by fundamental market needs, as downstream sectors prioritized operational continuity.
• Why did the price change in July 2025? With inventory rebalancing largely achieved and no signs of aggressive seasonal demand, the Monocalcium Phosphate Price Forecast for Europe in July 2025 leans toward moderation or slight softening, unless a raw material or energy cost shock occurs.
For the Quarter Ending March 2025
North America
In the first quarter of 2025 the Monocalcium Phosphate (Monohydrate) prices in North America saw a healthy rise of 5.94% on average. The increase was supported by strong demand from the pharmaceutical and food sectors. The production activity gradually picked up with the seasonal shift from winter to early spring. Several buyers across the region planned procurement in advance in anticipation of better demand in the coming quarter. This led to firm price levels in the entire North American region in the first quarter of 2025.
Tariff regulations remained in place but did not sharply affect the overall trade and prices. The supply situation stayed balanced as producers managed inventories well. Logistics also ran smoothly which allowed consistent movement of goods. Demand from downstream sectors like food processing and nutraceuticals improved as companies prepared for post-winter sales cycles.
Procurement was steady and most buyers restocked to ensure readiness for upcoming consumption. The positive demand and organized supply helped prices move upward in the region. Overall, the North American market remained active and optimistic with a clear upward trend in pricing throughout the quarter.
Asia Pacific
In Asia Pacific, the market for Monocalcium Phosphate (Monohydrate) recorded a modest average price increase of 0.12% during the first quarter of 2025 in comparison to the previous quarter. The region remained generally stable which was supported by seasonal changes and early-year adjustments. The Chinese Lunar New Year, which fell in the early part of the quarter had a slight impact and slowed production activity for a brief period. However, after the holiday, production resumed steadily and helped meet regular demand.
The seasonal transition played a quiet role in supporting production and consumption across the region. Procurement from downstream sectors such as food and beverages remained consistent. While the price rise was not sharp, it reflected balanced market behaviour. Inventories were handled with care and there was no major oversupply. Supply chains operated efficiently in most areas across APAC region. Even though the increase was small, it suggested that overall demand held firm.
The market moved gradually and was driven by practical procurement, regular offtakes and anticipation of the upcoming production cycle. The soft price movement reflected a stable outlook without large fluctuations across the Asia Pacific region during first quarter of 2025.
Europe
In European region the Monocalcium Phosphate (Monohydrate) prices rose by an average of 3.07% during the first quarter of 2025 compared the average prices in previous quarter. The European market remained stable and well-aligned with regional demand. Pharmaceutical and food industries showed improved activity as warmer temperatures arrived which observed increase of demand from end-user sector.
The seasonal shift encouraged higher production which helped to support regular procurement throughout the quarter. Buyers acted early to secure stock in the first quarter in anticipation of stronger usage in the upcoming period and aligned their inventories beforehand. This helped to keep prices elevated in the European region.
Suppliers ensured smooth deliveries, and inventories were well managed. There were no major supply chain hurdles during this period. Downstream demand stayed strong and procurement was paced to meet upcoming needs. The overall market sentiment in Europe remained positive. The steady rise in prices reflected healthy demand conditions and strong logistical support. The upward trend appeared gradual and driven by logical buying behaviour, aligning with improved activity in core application sectors like food and nutraceuticals.
For the Quarter Ending December 2024
North America
The U.S. Monocalcium Phosphate Market in Q4 2024 showcase a Volatile Quarter with a Downward Trend. The fourth quarter of 2024 saw a mixed yet overall downward pricing trend in the U.S. Monocalcium Phosphate market. October witnessed a sharp price surge due to heightened seasonal demand from food and beverage sectors, elevated shipping costs from Asian suppliers, supply chain constraints, and rising raw material prices. Strategic stockpiling and global disruptions in Ukraine and the Middle East compounded supply-side pressures, keeping prices high.
However, in November, prices declined significantly as reduced domestic inventories and lower export prices created arbitrage opportunities. Competitive pricing strategies for the holiday season, coupled with record cargo processing, further eased prices. Demand remained cautious, driven by cost-conscious purchasing rather than strong consumption.
December continued the downward trend, marked by weak demand from pharmaceuticals and oversupply due to elevated inventories and aggressive destocking efforts. Intense competition from Chinese imports added pressure, while new orders fell amid policy uncertainty. Despite the challenges, manufacturers increased employment but scaled back purchasing activity, reflecting subdued market sentiment.
Asia Pacific
Monocalcium Phosphate prices exhibited volatility in Q4 2024, with an overall downward trajectory following an initial surge in October.
In October, prices rose sharply in China due to logistical disruptions caused by severe typhoons, heightened procurement ahead of seasonal demand, and increased pharmaceutical sector consumption. Tight raw material supply, particularly Phosphoric Acid, added to the price pressure, with low inventories and robust buying activity amplifying the upward trend. However, China's economy showed early signs of recovery, with the manufacturing PMI rising to 50.1, though challenges like export declines and rising input costs persisted.
In November, prices declined as producers aggressively reduced inventory ahead of the holiday season, despite steady demand. Oversupply, weak downstream absorption, and geopolitical pressures, such as tariff uncertainties, exacerbated the decline, creating a buyer's market.
Overall, Q4 demonstrated a mixed trend—initial price increases followed by market corrections—driven by structural market conditions, seasonal dynamics, and external factors. The supply-demand imbalance is likely to persist until significant production cuts or demand improvements materialize.
Europe
The Monocalcium Phosphate market in Germany experienced a mixed trend in Q4 2024, starting with a steady price rise but ending with pronounced price declines. In early Q4 2024, Monocalcium Phosphate prices in Germany rose steadily due to constrained supply from key producers, elevated input costs, and strategic price hikes by domestic participants.
Divergent downstream demand, particularly in the pain relief industry, and tight phosphoric acid availability further amplified the bullish sentiment. However, November marked a significant shift as prices entered a downward trajectory due to subdued demand, reduced production costs, and persistent oversupply across the European market. Favorable production conditions, high inventory levels, and competitive buying opportunities pressured prices downward, prompting manufacturers to cut prices aggressively to manage inventories.
Weak downstream demand, cautious procurement, and Euro depreciation sustained the bearish sentiment throughout December. Surplus supply conditions, driven by pre-holiday stockpiling and favorable import dynamics, compounded the softening price trend. Overall, Q4 ended with bearish momentum as suppliers focused on inventory normalization rather than shifts in demand, delaying any prospects for price recovery.
For the Quarter Ending September 2024
North America
In Q3 2024, the North American Monocalcium Phosphate market experienced a consistent decline in prices, especially in the USA. Several factors contributed to this downward trend, primarily an abundant supply combined with weak demand on both domestic and international fronts. Consumption in downstream industries remained subdued, further disrupting the supply-demand balance. Reduced trading activity and lackluster demand from neighboring regions also played significant roles in the price decrease.
Additionally, a decline in raw material demand prompted manufacturers to cut back on production, marking the first contraction in supplier lead times in three months. End-users adopted a cautious purchasing strategy, focusing solely on essential needs, which dampened overall buying interest and perpetuated the negative market sentiment.
Throughout the quarter, the market outlook remained weak, reflecting persistent oversupply conditions and sluggish demand. The first half of the quarter saw a more pronounced price decrease compared to the latter half, concluding at USD 1490/MT CFR New York. The average quarterly decline was 0.16%, indicating a sustained downward pricing trend. Notably, there were no disruptions or plant shutdowns reported during this period.
Asia Pacific
In Q3 2024, the Monocalcium Phosphate market in the APAC region saw a steady price increase driven by multiple factors. Strong demand and limited supply, compounded by logistical challenges, created a favorable pricing environment. Increased industrial activity and robust international demand led to supply chain disruptions and cargo shortages, further straining supply. Ongoing plant maintenance and reduced inventory levels also contributed to the upward price trend.
China emerged as a significant player in the market, experiencing the most pronounced price fluctuations. The quarter exhibited a clear seasonal trend, with prices steadily rising compared to the same period last year. The market demonstrated a quarter-on-quarter increase of 9%, highlighting its positive momentum. By the end of Q3 2024, the price of Monocalcium Phosphate (Monohydrate) FOB Shanghai in China reached USD 1430/MT, marking an average quarterly increase of 2.45%.
This combination of strong demand, constrained supply, and logistical challenges underscores the dynamic nature of the Monocalcium Phosphate market in the region, positioning it for continued growth as industrial activities expand and international demand remains robust.
Europe
In Q3 2024, Monocalcium Phosphate prices in Europe, particularly in Germany, saw a notable decline. This trend was influenced by several factors, including reduced production costs stemming from lower energy expenses. The market also faced oversupply challenges due to weakened demand in various end-use sectors.
To manage storage costs and prevent product degradation, companies resorted to offloading excess inventories, further intensifying the supply glut. Traders were compelled to liquidate holdings to stabilize cash flow amid weak sales. Although the Euro appreciated against the USD, purchasing sentiment remained subdued, especially in southern Europe. Germany, as a major importer, was significantly impacted by these global and local factors, leading to a persistent decrease in Monocalcium Phosphate prices.
Throughout the quarter, a consistent downward trend was observed, particularly in August. The market is expected to remain under pressure until a substantial change occurs in supply or demand dynamics. By the end of Q3 2024, the price of Monocalcium Phosphate (Monohydrate) CFR Hamburg in China reached USD 1476/MT, reflecting a slight average quarterly increase of 0.75%.
FAQs
1. What is Monocalcium Phosphate used for?
Monocalcium Phosphate is primarily used as a feed additive in the animal nutrition industry, particularly in poultry and livestock diets, to enhance phosphorus and calcium intake. It is also used in fertilizers and occasionally as a leavening agent in the food industry.
2. How is Monocalcium Phosphate produced?
MCP is produced by reacting calcium carbonate (limestone) with phosphoric acid, resulting in a fine white powder or granular form. The product is then dried and processed into different grades based on application — feed, fertilizer, or food.
3. What is the difference between feed-grade and fertilizer-grade MCP?
Feed-grade Monocalcium Phosphate is highly purified to meet nutritional and safety standards for animal consumption. In contrast, fertilizer-grade MCP is formulated to enhance soil phosphorus content and may contain higher levels of impurities not suitable for feed or food applications.
4. How should Monocalcium Phosphate be stored?
MCP should be stored in a dry, well-ventilated area away from moisture, as it is hygroscopic. Proper storage conditions prevent caking, degradation, and contamination, especially when intended for feed applications.
5. What factors influence the market price of Monocalcium Phosphate?
Key drivers include the cost of raw materials (especially phosphoric acid and limestone), regional demand trends in livestock farming, agricultural fertilizer usage, regulatory policies, and global phosphate availability. Seasonal demand from feed producers can also impact pricing.
